(ARWR) Arrowhead - Performance -47.5% in 12m
Compare ARWR with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-78.06%
#110 in Group
Rel. Strength
15.07%
#6758 in Universe
Total Return 12m
-47.46%
#91 in Group
Total Return 5y
-63.50%
#67 in Group
P/E -
(?) Percentile in Group
P/E Forward 111
94th Percentile in Group
PEG -1.32
22th Percentile in Group
FCF Yield -34.02%
(?) Percentile in Group
12m Total Return: ARWR (-47.5%) vs XBI (-12.3%)

5y Drawdown (Underwater) Chart

Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
---|---|---|---|---|---|---|---|---|
UTHR NASDAQ United Therapeutics |
10.1% | 18% | 166% | 12.1 | 11 | 1.43 | 74.6% | 16.1% |
HLN NYSE Haleon |
14.3% | 31.2% | 47% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
AMGN NASDAQ Amgen |
-2.93% | -8.78% | 30.7% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
LONN SW Lonza |
9.55% | 9.34% | 30.4% | 67.1 | 35.1 | 1.28 | 2.20% | -12.5% |
BIM PA Biomerieux |
0.78% | 17.8% | -2.14% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
KMDA NASDAQ Kamada |
21.4% | 25.3% | -4.13% | 26.6 | 23.9 | 0.96 | 32.5% | 3.93% |
NBIX NASDAQ Neurocrine Biosciences |
34.3% | -15.5% | 3.48% | 32.3 | 21.6 | 0.27 | 68.0% | 31.9% |
ERF PA Eurofins Scientific SE |
20.4% | -0.39% | 7.63% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: ARWR vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for ARWR
Total Return (including Dividends) | ARWR | XBI | S&P 500 |
---|---|---|---|
1 Month | 32.63% | 11.81% | 13.81% |
3 Months | -33.48% | -13.61% | -6.30% |
12 Months | -47.46% | -12.29% | 10.65% |
5 Years | -63.50% | -24.89% | 107.77% |
Trend Score (consistency of price movement) | ARWR | XBI | S&P 500 |
1 Month | 77.4% | 72.9% | 83% |
3 Months | -81.8% | -83% | -75.3% |
12 Months | -84.0% | -51.6% | 50.1% |
5 Years | -86.4% | -53.9% | 84.1% |
Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
1 Month | #63 | 18.6% | 16.5% |
3 Month | #123 | -23.0% | -29.0% |
12 Month | #92 | -40.1% | -52.5% |
5 Years | #68 | -51.4% | -82.4% |
FAQs
Does ARWR Arrowhead outperforms the market?
No,
over the last 12 months ARWR made -47.46%, while its related Sector, the SPDR S&P Biotech (XBI) made -12.29%.
Over the last 3 months ARWR made -33.48%, while XBI made -13.61%.
Over the last 3 months ARWR made -33.48%, while XBI made -13.61%.
Performance Comparison ARWR vs Indeces and Sectors
ARWR vs. Indices ARWR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
US S&P 500 | SPY | -6.81% | 18.8% | -34.5% | -58.1% |
US NASDAQ 100 | QQQ | -7.0% | 15.3% | -34.7% | -59.1% |
US Dow Jones Industrial 30 | DIA | -7.22% | 22.6% | -34.2% | -55.2% |
German DAX 40 | DAX | -6.79% | 17.7% | -60.8% | -73.2% |
Shanghai Shenzhen CSI 300 | CSI 300 | -8.99% | 20.8% | -35.3% | -54.8% |
Hongkong Hang Seng | HSI | -9.98% | 12.7% | -42.9% | -61.1% |
India NIFTY 50 | INDA | -1.89% | 27.8% | -35.0% | -47.3% |
Brasil Bovespa | EWZ | -7.86% | 15.4% | -43.2% | -39.1% |
ARWR vs. Sectors ARWR is Over or Underperforming
Symbol | 1w | 1m | 6m | 12m | |
---|---|---|---|---|---|
Communication Services | XLC | -7.45% | 19.2% | -41.6% | -69.0% |
Consumer Discretionary | XLY | -7.19% | 18.4% | -33.6% | -61.7% |
Consumer Staples | XLP | -5.95% | 26.0% | -41.5% | -56.6% |
Energy | XLE | -6.63% | 25.9% | -27.9% | -38.0% |
Financial | XLF | -7.91% | 19.1% | -41.6% | -69.9% |
Health Care | XLV | -3.80% | 31.8% | -29.5% | -43.4% |
Industrial | XLI | -8.50% | 15.8% | -36.0% | -58.5% |
Materials | XLB | -6.61% | 19.1% | -29.6% | -42.2% |
Real Estate | XLRE | -5.49% | 21.1% | -35.3% | -62.9% |
Technology | XLK | -7.89% | 11.4% | -31.7% | -54.6% |
Utilities | XLU | -6.86% | 23.0% | -42.2% | -64.9% |
Aerospace & Defense | XAR | -8.79% | 11.5% | -46.0% | -74.8% |
Biotech | XBI | -0.22% | 20.8% | -14.4% | -35.2% |
Homebuilder | XHB | -7.28% | 21.2% | -21.3% | -39.9% |
Retail | XRT | -8.71% | 18.0% | -30.3% | -46.0% |